Control of cell proliferation and differentiation by the Retinoblastoma tumor suppressor pathway
Control of cell proliferation and differentiation by the Retinoblastoma tumor suppressor pathway
批准号:
10794727
负责人:
Maxim Frolov
金额:
$3.4万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-05-01 至 2024-04-30
关键词:
AddressAdultAffectAnimalsApoptosisAtlasesCell Differentiation processCell ProliferationCellsComplementDevelopmentDrosophila genusE2F transcription factorsEventEyeFamilyFat BodyGene ExpressionGeneticGenomicsGrowthHumanInvestigationKnowledgeLinkMalignant NeoplasmsMetabolismMuscle DevelopmentMutationMyofibrillogenesisPathway interactionsPhotoreceptorsPopulationProtein FamilyProteinsResearchRetinoblastomaRetinoblastoma ProteinSkeletal MuscleSystemTechnologyTissuesTumor Suppressor Proteinscell typedroplet sequencingflygenetic analysisimaginal discin vivoinnovationmembermodel organismmutantprogramsretinoblastoma pathwayretinoblastoma tumor suppressorsingle-cell RNA sequencing
中文摘要
项目总结/摘要
视网膜母细胞瘤(Rb)肿瘤抑制通路的失活是视网膜母细胞瘤(Rb)的早期必然事件。
人类癌症Rb通路的关键靶点之一是E2 F转录家族
因子,其调节细胞增殖和凋亡。的重叠和冗余功能
E2 F和Rb肿瘤抑制蛋白(pRB)家族的哺乳动物成员是一个主要的肿瘤抑制蛋白。
在鉴定其体内功能方面存在障碍。果蝇等模式生物提供了
有吸引力的替代品,以补充哺乳动物系统中的研究,由于高度保守的
Rb通路和果蝇对遗传分析的顺从性。我们的研究计划旨在
在解决两个基本问题:什么是Rb途径的基本功能,
Rb通路突变如何影响组织中不同的细胞类型?到
为了解决这些问题,我们正在使用遗传,基因组和单细胞RNA-seq方法。
我们已经确定了E2 F和Rb蛋白调节生长的成人骨骼肌,
肌原纤维形成,这对生存力很重要。我们将确定Rb通路是如何
调节肌肉发育过程中的基因表达和细胞代谢,
研究E2 F缺乏在特定组织(如成人)中推断的全身效应。
骨骼肌和脂肪体。我们已经调整了Drop-seq,一种单细胞RNA测序,
技术,以确定Rb途径突变在异质组织中的作用。我们有
通过建立第一个果蝇野生细胞图谱,
型眼影像盘。通过Drop-Seq分析Rb突变体揭示了细胞内
酸化在小细胞群体,使他们独特的敏感性凋亡。链路
将进一步评估细胞凋亡和酸化之间的关系。在其他问题中,
用Drop-seq解决的是为什么Hippo通路的失活会诱导
Rb突变型光感受器的去分化。总体而言,拟议的研究将提高
我们对pRB及其在动物发育过程中的功能的了解。
英文摘要
PROJECT SUMMARY/ABSTRACT
Inactivation of the retinoblastoma (Rb) tumor suppressor pathway is an early obligatory event in
human cancer. One of the key targets of the Rb pathway is the family of E2F transcription
factors, which regulate cell proliferation and apoptosis. Overlapping and redundant functions of
mammalian members of the E2F and Rb tumor suppressor protein (pRB) families is a major
hurdle in identification of their in vivo function. Model organisms such as Drosophila provide
attractive alternatives to complement studies in mammalian systems due to high conservation of
the Rb pathway and the amenability of flies to genetic analysis. Our research program is aimed
at addressing two fundamental questions: what are the essential functions of the Rb pathway in
development, and how do Rb pathway mutations affect different cell types in the tissue? To
address these questions, we are using genetic, genomic and single-cell RNA-seq approaches.
We have identified adult skeletal muscle where E2F and Rb proteins regulate growth and
myofibrillogenesis, which is important for viability. We will determine how the Rb pathway
regulates gene expression and cellular metabolism during muscle development, and will
investigate the systemic effects inferred by E2F deficiency in specific tissues such as adult
skeletal muscle and the fat body. We have adapted Drop-seq, a single-cell RNA-sequencing
technology, to determine the effect of Rb pathway mutations in heterogeneous tissue. We have
established the feasibility of this approach by building the first cell atlas of the Drosophila wild-
type eye imaginal disc. Profiling of Rb mutants by Drop-Seq revealed elevated intracellular
acidification in a small cell population that makes them uniquely sensitive to apoptosis. The link
between apoptosis and acidification will be evaluated further. Among other questions to be
addressed with Drop-seq is the investigation of why inactivation of the Hippo pathway induces
dedifferentiation of Rb mutant photoreceptors. Collectively, the proposed research will enhance
our knowledge of pRB and its functions during animal development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Control of cell proliferation and differentiation by the Retinoblastoma tumor suppressor pathway
-
批准号:10396992
-
项目类别:
-
资助金额:$57.02万
-
财政年份:2019
-
负责人:Maxim Frolov
-
依托单位:
Control of cell proliferation and differentiation by the Retinoblastoma tumor suppressor pathway
-
批准号:10611940
-
项目类别:
-
资助金额:$57.02万
-
财政年份:2019
-
负责人:Maxim Frolov
-
依托单位:
Control of cell proliferation and differentiation by the Retinoblastoma tumor suppressor pathway
-
批准号:9908112
-
项目类别:
-
资助金额:$57.02万
-
财政年份:2019
-
负责人:Maxim Frolov
-
依托单位:
Functional interaction between the mir11~998 intronic microRNA cluster and Retinoblastoma tumor suppressor pathway
-
批准号:8991496
-
项目类别:
-
资助金额:$31.97万
-
财政年份:2015
-
负责人:Maxim Frolov
-
依托单位:
Functional interaction between the mir11~998 intronic microRNA cluster and Retinoblastoma tumor suppressor pathway
-
批准号:8816779
-
项目类别:
-
资助金额:$31.96万
-
财政年份:2015
-
负责人:Maxim Frolov
-
依托单位:
Genetic integration of pRB and Hippo tumor suppressor pathways
-
批准号:8319369
-
项目类别:
-
资助金额:$29.65万
-
财政年份:2011
-
负责人:Maxim Frolov
-
依托单位:
Genetic integration of pRB and Hippo tumor suppressor pathways
-
批准号:8708116
-
项目类别:
-
资助金额:$29.65万
-
财政年份:2011
-
负责人:Maxim Frolov
-
依托单位:
Rb and Hippo tumor suppressor pathways in differentiation
-
批准号:9355642
-
项目类别:
-
资助金额:$33.58万
-
财政年份:2011
-
负责人:Maxim Frolov
-
依托单位:
Genetic integration of pRB and Hippo tumor suppressor pathways
-
批准号:8019364
-
项目类别:
-
资助金额:$28.46万
-
财政年份:2011
-
负责人:Maxim Frolov
-
依托单位:
Genetic integration of pRB and Hippo tumor suppressor pathways
-
批准号:8514010
-
项目类别:
-
资助金额:$28.62万
-
财政年份:2011
-
负责人:Maxim Frolov
-
依托单位:
Characterization of novel modifiers of dE2F/RBF function
-
批准号:8054279
-
项目类别:
-
资助金额:$25.83万
-
财政年份:2007
-
负责人:Maxim Frolov
-
依托单位:
Characterization of novel modifiers of dE2F/RBF function
-
批准号:7195896
-
项目类别:
-
资助金额:$26.35万
-
财政年份:2007
-
负责人:Maxim Frolov
-
依托单位:
Characterization of novel modifiers of dE2F/RBF function
-
批准号:7589721
-
项目类别:
-
资助金额:$26.35万
-
财政年份:2007
-
负责人:Maxim Frolov
-
依托单位:
Characterization of novel modifiers of dE2F/RBF function
-
批准号:7351791
-
项目类别:
-
资助金额:$26.35万
-
财政年份:2007
-
负责人:Maxim Frolov
-
依托单位:
Characterization of novel modifiers of dE2F/RBF function
-
批准号:7778250
-
项目类别:
-
资助金额:$26.09万
-
财政年份:2007
-
负责人:Maxim Frolov
-
依托单位:
海外基金